In this renewal application, the overall objective of this established and successful multidisciplinary training program in Digestive Diseases continues to be to train qualified postdoctoral individuals (M.D., and/or Ph.D.) for academic careers in gastroenterology and hepatology. The grant includes 33 Full Faculty (a net increase of 3 faculty since the last renewal) from both clinical and basic science departments with two tracks for potential trainees: i) basic/disease oriented research;and ii) patient-oriented research. The basic/disease oriented research tract remains one of long-standing excellence with training opportunities in cell biology, cancer biology, neuromuscular sciences, and experimental surgery/transplantion [sic] research. Training in this track is strongly supported through interactions with the NIH funded Mayo Comprehensive Cancer Center and Departments of Biochemistry/Molecular Biology, Pharmacology, Immunology, and Physiology. The patient-oriented research tract, which has seen recent expansion, maintains training opportunities in epidemiology/outcomes, human trials, and also a new initiative that encompasses Obesity and Nutrition. Training in this track is strongly buttressed by a recently awarded NIH Clinical Translational Science Award to Mayo Clinic. New R01 funded faculty have been added in all the tracks;especially those with an emphasis on Pediatrics or Nutrition. We continue to request support for 5 postdoctoral trainees per year that are selected through objective and consensus-driven mechanisms from a very large and talented pool of M.D., PhD, or M.D./PhD candidates derived from a variety of clinical and basic disciplines. The overall success of the program continues to be outstanding with 70% of former trainees over the last 10 years maintaining staff appointments within academic medicine and a funding portfolio from this cohort that includes 7 new NIH grants. Our aggressive recruitment of both female and underrepresented minority candidates also continues, with 44 % of the candidates deriving from female or minority groups during the last 10 years. This approach is strengthened by increased faculty representation of females and underrepresented minorities. Thus, this well established training program remains nimble and innovative, thereby continuing to be highly successful in achieving its goal of training individuals for academic careers in gastroenterology and hepatology.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mayo Clinic, Rochester
United States
Zip Code
Yang, Ju Dong; Addissie, Benyam D; Mara, Kristin C et al. (2018) GALAD Score for Hepatocellular Carcinoma Detection in Comparison to Liver Ultrasound and Proposal of GALADUS Score. Cancer Epidemiol Biomarkers Prev :
Yang, Ju Dong; Mannalithara, Ajitha; Piscitello, Andrew J et al. (2018) Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis. Hepatology 68:78-88
Wang, Ruisi; Ding, Qian; De Assuncao, Thiago M et al. (2017) Hepatic Stellate Cell Selective Disruption of Dynamin-2 GTPase Increases Murine Fibrogenesis through Up-Regulation of Sphingosine-1 Phosphate-Induced Cell Migration. Am J Pathol 187:134-145
Maiers, Jessica L; Kostallari, Enis; Mushref, Malek et al. (2017) The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice. Hepatology 65:983-998
Yang, Ju Dong; Altekruse, Sean F; Nguyen, Mindie H et al. (2017) Impact of country of birth on age at the time of diagnosis of hepatocellular carcinoma in the United States. Cancer 123:81-89
Yang, Ju Dong; Ahmed Mohammed, Hager; Harmsen, William S et al. (2017) Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota: A US Population-based Study. J Clin Gastroenterol 51:742-748
Yang, Ju Dong; Larson, Joseph J; Watt, Kymberly D et al. (2017) Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States. Clin Gastroenterol Hepatol 15:767-775.e3
Robinson, Matthew M; Dasari, Surendra; Konopka, Adam R et al. (2017) Enhanced Protein Translation Underlies Improved Metabolic and Physical Adaptations to Different Exercise Training Modes in Young and Old Humans. Cell Metab 25:581-592
Tabibian, James H; Gossard, Andrea; El-Youssef, Mounif et al. (2017) Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis. Am J Ther 24:e56-e63
Hicks, S B; Tabibian, J H (2017) Molecular Adsorbent Recirculating System as a Diagnostic and Therapeutic Modality. J Mol Genet Med 11:

Showing the most recent 10 out of 150 publications